FSC Elaborates Testing Process for 'Patient Alpha'

CANOGA PARK, Calif.— The Free Speech Coalition on Wednesday elaborated on the process of testing that took place for the adult performer identified as Patient Alpha.

The FSC, with cooperation from the performer, reconstructed the process of testing Patient Alpha, which resulted in what is now believed to be at least one false positive result and touched off a week-long industry moratorium on content production.

According to reports from the performer, initial tests showed that on Aug. 20 a PCR/NAT test was administered, resulting in “reactive,” an indication of HIV exposure.

The test was followed up with Western Blot and ELISA tests, which both turned up negative.

A secondary PCR/DNA test on Aug. 29, administered by Talent Testing Services, reported “reactive,” and later Western Blot and ELISA tests produced negative results.

On Aug. 31, Patient Alpha is contacted by TTS and told that results of an additional PCR/DNA test on original blood sample is negative

Patient Alpha, on Sept. 3, then tested at Advanced Medical Testing Centers, where PCR/RNA, Western blot and ELISA all turn up negative.

"FSC would like to add that none of the results for tests taken outside of APHSS.org program can be confirmed at this time, except as reported by the patient. Neither UniLabExpress or Talent Testing Services are participants in APHSS.org," the FSC said in a statement.

"Patient Alpha  has signed a medical information release waiver and  APHSS.org medical advisers have requested copies of the raw data of the test results from Talent Testing Services. There has been no response at this time."

The FSC said that PCR/RNA is the only HIV test approved by the FDA for diagnosis of “primary or accute infection,” but also must be confirmed with supplementary tests.

"This is a more recently-developed test than the PCR/DNA, which has become industry standard for monthly testing of performers," the FSC said.

"When test results were returned by Advanced Medical Testing Centers and after consultation with APHSS.org medical advisers, FSC/APHSS.org was satisfied that the moratorium on content production could be lifted on this past Saturday."

Related:  

Copyright © 2026 Adnet Media. All Rights Reserved. XBIZ is a trademark of Adnet Media.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.

More News

'SheHerGirls' Launches Through Paysite.com

The braintrust behind PoleVixens has officially launched a new membership site, SheHerGirls, also through Paysite.com.

FTC Invites Public Comment on 'Click to Cancel' Rulemaking

The Federal Trade Commission (FTC) announced this week that it is seeking public comment on whether it should amend its Negative Option Rule to better address deceptive or unfair practices.

'PSMTickling' Launches Through Paysite.com

PSMTickling.com has officially launched through Paysite.com.

JuicyAds Marks 20-Year Anniversary

JuicyAds is celebrating its 20th anniversary.

AEBN Publishes Popular Searches for January, February

AEBN has published the top search terms for January and February from its straight and gay theaters in all 50 states and the District of Columbia.

2026 TEAs Shine Bright in Celebration and Solidarity

The industry’s trans adult performers, creators and creatives came together Sunday night at the historic Avalon nightclub in Hollywood for an evening of well-deserved celebration: the 2026 Trans Erotica Awards.

Kansas Plaintiff Drops Chaturbate AV Suit, Revamps SuperPorn Complaint

The plaintiff in a lawsuit alleging that cam platform Chaturbate violated Kansas’ age verification law has voluntarily dismissed that action, while retooling a similar complaint against adult site SuperPorn.

New Creator Networking Platform 'CollabGPS' Launches

CollabGPS, a new creator networking platform designed to facilitate safe collaboration, has officially launched.

Chaturbate Launches Yearlong 15th Anniversary Campaign

Chaturbate has launched a yearlong campaign to celebrate its 15th anniversary, titled “CB15.”

Show More